Genovate Biotechnology Balance Sheet

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	352.36	169.04	221.6	180.03	194.17	198.44
Short-Term Investments	715.91	265.16	259.67	324.03	282.88	177.98
Trading Asset Securities	42.64	47.76	40.2	35.25	20	13
Cash & Short-Term Investments	1,111	481.96	521.47	539.3	497.05	389.42
Cash Growth	119.06%	-7.58%	-3.31%	8.50%	27.64%	-7.54%
Accounts Receivable	81.53	86.24	89.06	87.87	96.13	94.39
Other Receivables	2.4	1.32	1.4	1.28	27.77	0.77
Receivables	83.93	87.57	90.46	89.15	123.89	95.16
Inventory	138.95	143.83	145.87	139.64	145.86	139.94
Prepaid Expenses	12.55	5.94	7.34	3.39	14.79	10.38
Other Current Assets	-	0.01	0.31	0.29	0.28	0.02
Total Current Assets	1,346	719.3	765.45	771.77	781.88	634.93
Property, Plant & Equipment	404.62	410.42	393.95	392.12	403.29	409.6
Long-Term Investments	310.9	339.53	398.55	397.28	351.6	439.52
Other Intangible Assets	5.38	6.19	3.11	4.66	0.8	1.49
Other Long-Term Assets	31.24	30.93	29.16	34.62	26.87	29.97
Total Assets	2,098	1,506	1,590	1,600	1,564	1,516
Accounts Payable	26.95	29.97	40.28	32.87	45.91	35
Accrued Expenses	-	35.06	37.49	29.57	35.55	29.4
Current Portion of Leases	1.32	1.23	0.86	0.67	1.25	0.74
Current Income Taxes Payable	0.07	0.18	4.39	1.37	3.27	3.4
Current Unearned Revenue	2.02	1.79	1.96	4.9	4.73	4.03
Other Current Liabilities	75.9	57.1	51.5	48.36	41.12	38.05
Total Current Liabilities	106.26	125.32	136.48	117.73	131.84	110.61
Long-Term Leases	0.25	0.61	1.73	0.02	0.59	0.09
Pension & Post-Retirement Benefits	-	-	2.75	13.7	21.06	25.82
Other Long-Term Liabilities	0.12	0.12	0.12	0.24	0.12	0.12
Total Liabilities	106.62	126.05	141.08	131.69	153.6	136.65
Common Stock	1,379	1,149	1,127	1,094	1,094	1,100
Additional Paid-In Capital	631.58	210.71	210.66	210.56	210.51	208.93
Retained Earnings	120.47	131.77	152.63	177.79	202.18	167.97
Treasury Stock	-25.72	-25.72	-25.72	-	-	-63.03
Comprehensive Income & Other	-113.35	-85.32	-15.01	-13.34	-95.62	-35.04
Shareholders' Equity	1,992	1,380	1,449	1,469	1,411	1,379
Total Liabilities & Equity	2,098	1,506	1,590	1,600	1,564	1,516
Total Debt	1.57	1.84	2.58	0.68	1.84	0.83
Net Cash (Debt)	1,109	480.12	518.88	538.62	495.21	388.59
Net Cash Growth	119.86%	-7.47%	-3.66%	8.77%	27.44%	-7.29%
Net Cash Per Share	9.75	4.22	4.52	4.68	4.37	3.43
Filing Date Shares Outstanding	113.75	113.75	113.75	114.91	114.91	113.33
Total Common Shares Outstanding	113.75	113.75	113.75	114.91	114.91	113.33
Working Capital	1,240	593.98	628.97	654.05	650.04	524.32
Book Value Per Share	17.51	12.13	12.74	12.78	12.28	12.17
Tangible Book Value	1,986	1,374	1,446	1,464	1,410	1,377
Tangible Book Value Per Share	17.46	12.08	12.71	12.74	12.27	12.15
Land	-	140.74	140.74	140.74	140.74	140.74
Buildings	-	284.41	285.06	282.26	281.85	283.17
Machinery	-	136.25	168.27	158.6	180.44	160.91
Construction In Progress	-	36.53	2.49	1.88	0.61	0.41